Clinical Trials Browser

INDUSTRY × Blood Specimen Collection × Thoracic × Clear all

Lung Neoplasms

NCT04951154 2025-08-19

A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

Completed

33 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06605404 2025-08-14

Pan-tumor MRD Study

Recruiting

1,350 enrolled

DermatologicGastrointestinalThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Melanoma

NCT06122077 2025-08-05

PROACT-LUNG

Recruiting

20,000 enrolled

Thoracic

Emphysema, Lung Neoplasms, Respiratory Distress Syndrome, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic

NCT06245876 2024-02-12

Lung EpiCheck Biomarkers Development Study

Unknown

6,000 enrolled

Thoracic

Lung Neoplasms

NCT04180176 2024-01-17

PCG

Phase 4 Completed

945 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT05736029 2023-02-21

PROPHETIC

Recruiting

350 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04136470 2020-08-10

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Unknown

130 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms

NCT04145232 2020-08-10

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00685750 2019-06-20

Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma

Phase NA Terminated

88 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

Pan-tumor MRD Study

PROACT-LUNG

Lung EpiCheck Biomarkers Development Study

PCG

PROPHETIC

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma